← SynDRA
CLOFAZIMINE
SynDRA canonical compound SYN0005091 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | GK0582 inhibitor |
| Indication | leprosy |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
Drug classes
- Antimycobacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Inflammatory Agents
- Leprostatic Agents
ATC classes
- DRUGS FOR TREATMENT OF LEPRA
Cross-references
Synonyms
- lamprene
- chlofazimine
- Clofazimina
- Chlofazimine
- Clofaziminum
- Colfazimine
- G-30320
- G30320
- NSC-141046
- Lamprene
- Lampren
- Clofaziminum [INN-Latin]
- B 663 (Pharmaceutical)
- Clofazimina [INN-Spanish]
- B 663
- UNII-D959AE5USF
- B 663 (VAN)
- C27H22Cl2N4
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
- 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
- EINECS 217-980-2
- CFZ
- SMP2_000339
- B 663, pharmaceutical
- Lamprene (TN)
- Liposome-encapsulated clofazimine
- Clofazimine [USAN:INN:BAN]
- G-30,320
- Clofazimine (JAN/USP/INN)
- N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
- N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
- (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
Look up CLOFAZIMINE in the interactive SynDRA portal →